🇺🇸 FDA

Drug profile · INN

paclitaxel

ABRAXANE

approved L01CD01
US status
approved
Patents linked
5
News articles
0

Quick answer

paclitaxel (ABRAXANE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN paclitaxel
Brand ABRAXANE
Route INJECTION
Formulation INJECTABLE
ATC code L01CD01
Originator Regeneron Ireland Designated Activity Company (DAC)

Related patents

Search patents →

  1. US 11944617

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11285145

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8426385

    Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7179588

    Assay for the detection of paclitaxel resistant cells in human tumors

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 6569459

    Method of administration of paclitaxel-plasma protein formulation

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is paclitaxel?

paclitaxel (ABRAXANE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for paclitaxel?

ABRAXANE is a marketed brand name for paclitaxel. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of paclitaxel?

paclitaxel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.